- Protech Home Medical (PTQ) is opening two new locations focused on respiratory therapy products and services
- The new locations are in Daytona Beach, Florida and Concord, New Hampshire
- The Daytona Beach location is expected to help the company’s ongoing expansion effort in the area
- The location is also expected to help cut down on logistical costs
- Protech Home Medical is down 3.41 per cent on the day, with shares of the company trading at C$1.98 at 12:02 pm ET
Protech Home Medical (PTQ) is opening two new locations focused on respiratory therapy products and services.
The U.S.-based leader in the home medical equipment industry continues to focus on end-to-end respiratory care.
The two new locations are in Daytona Beach, Florida and Concord, New Hampshire.
The Daytona Beach location is expected to help the company’s ongoing expansion effort in that state.
The location will have a heavily respiratory weighted product mix which is also expected to help cut down on logistical costs.
“With the addition of new locations in Florida and New Hampshire we continue our aggressive path of scaling our business. We believe coupling organic initiatives such as strategically opening new locations, combined with our robust acquisition plans has significantly widened our aperture of opportunity for our business,” said Protech Chairman and CEO Greg Crawford.
“Our patient centric model leveraging our interconnected healthcare platform is providing us much opportunity to gain market share and this is just the beginning for us. We have additional plans to increase our footprint in current markets as well as adding new markets in our pursuit of becoming a leading national provider of respiratory therapy products and services in the home. Moreover, we must ensure our brand aligns with our mission, ensuring we are building strong brand equity to further accelerate organic growth opportunities, and we expect to have more to share on this front in the near future. Finally, we are incredibly excited about our deep pipeline of potential acquisition targets, which we expect to be very busy in the near term and look forward to updating shareholders when appropriate.”
Protech Home Medical provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market.
Protech Home Medical is down 3.41 per cent on the day, with shares of the company trading at C$1.98 at 12:02 pm ET.
